Related Experiment Video
Updated: Apr 23, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Searching for phenotypes in smoking cessation treatment
C A Jiménez-Ruiz1, J F Pascual Lledó, A Cicero Guerrero
1Smoking Cessation Service, County of Madrid, Spain.
Identifying smoking phenotypes is key for effective cessation. Tailoring treatments based on age, dependence, and therapy type improves quit rates in clinical practice.
Area of Science:
- Clinical Medicine
- Public Health
- Addiction Research
Background:
- Defining smoking phenotypes by variables like age, sex, and nicotine dependence is crucial for optimizing treatment efficacy.
- Current smoking cessation strategies may vary in effectiveness depending on individual patient characteristics.
Purpose of the Study:
- To define smoking phenotypes by analyzing combinations of patient variables.
- To guide the selection of the most effective smoking cessation treatments in routine clinical practice.
Main Methods:
- Retrospective review of clinical records from 3622 patients treated at a Smoking Cessation Service.
- Treatment programs included a combination of behavioral therapy and optional pharmacotherapy.
- Multivariate logistic regression analysis was used to identify factors influencing treatment outcomes.
Main Results:
- Continuous abstinence rates at 9-24 weeks were 57.7% for the overall sample.
- Nicotine Replacement Therapy showed reduced efficacy in highly dependent smokers.
- Younger smokers exhibited resistance to treatments, while low-dependence smokers responded well to various therapies, with bupropion and varenicline showing superior results.
Conclusions:
- Distinct smoking phenotypes exist, influencing the efficacy of different cessation treatments.
- Personalized treatment approaches based on identified phenotypes can enhance smoking cessation success.
More Related Videos
06:07Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Drug Abuse and Addiction: Pharmacological Phenomena
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...